DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $667,000 | -64.7% | 2,629 | -59.2% | 0.19% | -50.1% |
Q1 2022 | $1,889,000 | -17.6% | 6,440 | -7.6% | 0.39% | -13.6% |
Q4 2021 | $2,293,000 | +10.5% | 6,970 | +2.3% | 0.45% | -2.0% |
Q3 2021 | $2,075,000 | -0.8% | 6,816 | +0.6% | 0.46% | +0.2% |
Q2 2021 | $2,092,000 | +43.0% | 6,773 | +4.2% | 0.46% | +33.9% |
Q1 2021 | $1,463,000 | +1.9% | 6,498 | +0.5% | 0.34% | +4.9% |
Q4 2020 | $1,436,000 | +0.8% | 6,464 | -2.3% | 0.33% | -22.4% |
Q3 2020 | $1,424,000 | +22.0% | 6,613 | +0.2% | 0.42% | +6.6% |
Q2 2020 | $1,167,000 | +13.1% | 6,599 | -11.5% | 0.39% | -1.0% |
Q1 2020 | $1,032,000 | -7.1% | 7,458 | +3.1% | 0.40% | +22.5% |
Q4 2019 | $1,111,000 | +6.4% | 7,236 | +0.1% | 0.32% | -14.2% |
Q3 2019 | $1,044,000 | -5.9% | 7,230 | -6.9% | 0.38% | +8.9% |
Q2 2019 | $1,110,000 | -5.9% | 7,765 | -13.0% | 0.35% | -28.7% |
Q1 2019 | $1,179,000 | +12.5% | 8,930 | -12.1% | 0.49% | +4.9% |
Q4 2018 | $1,048,000 | +21.9% | 10,160 | +28.4% | 0.46% | +42.6% |
Q3 2018 | $860,000 | +10.0% | 7,915 | -0.1% | 0.33% | +8.7% |
Q2 2018 | $782,000 | +2.8% | 7,925 | +1.9% | 0.30% | -13.5% |
Q1 2018 | $761,000 | +0.5% | 7,775 | -4.7% | 0.35% | -13.0% |
Q4 2017 | $757,000 | +56.4% | 8,160 | +44.7% | 0.40% | +90.9% |
Q3 2017 | $484,000 | +512.7% | 5,640 | +509.7% | 0.21% | +242.6% |
Q1 2017 | $79,000 | – | 925 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |